Showing results (51-60 of 525) with videos related to
Sort By:
Pageof 53
British Journal of Clinical Pharmacology|November 1, 1987
Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in manH Sinzinger, P Fitscha, J Kaliman, et al.Experientia|November 15, 1978
Prostacyclin-like activity of endothelium and subendothelium - important for atherosclerosis?K Silberbauer, H Sinzinger, M Winter, et al.Wiener Klinische Wochenschrift|July 10, 1981
[Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)]K Klein, H Sinzinger, G Schernthaner, et al.Cardiology|January 1, 1981
Plasma concentrations of plbatelet-specific proteins in coronary artery diseaseI Mühlhauser, G Schernthaner, K Silberbauer, et al.Artery|January 1, 1980
Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseasesI Mühlhauser, G Schernthaner, K Silberbauer, et al.Lancet (London, England)|December 15, 1984
Detection of aneurysms by gamma-camera imaging after injection of autologous labelled plateletsH Sinzinger, J O'Grady, P Fitscha, et al.Chest|July 1, 1986
Platelet sensitivity to prostacyclin in smokers and non-smokersO C Burghuber, C Punzengruber, H Sinzinger, et al.Japanese Circulation Journal|March 1, 1976
Alterations of the internal elastic membrane in the coeliac trunk and its branchesH Sinzinger, W Feigl, C Leithner, et al.Wiener Klinische Wochenschrift|February 3, 1984
[111-Indium-labeled thrombocytes in the diagnosis of acute kidney transplant rejections and in monitoring the therapy of rejection reactions with prostacyclin]C Leithner, H Sinzinger, E Pohanka, et al.Experimentelle Pathologie|January 1, 1980
Prostacyclin (PGI2)-generation by different types of human atherosclerotic lesionsH Sinzinger, W Feigl, K Silberbauer, et al.Pageof 53